Development
Ultralife Corporation
ULBI
$7.78
$0.081.04%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 656.49% | 552.34% | -105.95% | 80.19% | 59.15% |
| Total Depreciation and Amortization | -12.89% | -13.57% | -15.12% | 12.92% | 33.61% |
| Total Amortization of Deferred Charges | 100.00% | 60.00% | 128.57% | -57.69% | -69.23% |
| Total Other Non-Cash Items | 449.24% | 595.65% | -16.50% | 50.00% | -40.43% |
| Change in Net Operating Assets | -207.69% | -96.78% | 55.84% | 146.68% | -191.23% |
| Cash from Operations | -108.20% | 1,083.71% | 57.64% | 161.98% | -128.33% |
| Capital Expenditure | 34.16% | -141.12% | -33.96% | 42.24% | 26.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 34.16% | -141.12% | -33.96% | 98.82% | 26.21% |
| Total Debt Issued | 8.33% | 1,900.00% | 58.62% | -100.00% | -- |
| Total Debt Repaid | 0.00% | 0.00% | -50.15% | -420.83% | -25.94% |
| Issuance of Common Stock | 32,533.33% | -- | -- | -- | -96.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 34.21% | -- |
| Cash from Financing | 86.42% | 464.10% | 47.18% | -107.67% | 430.71% |
| Foreign Exchange rate Adjustments | 109.38% | -3.48% | -757.14% | -131.25% | -1,263.64% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,715.87% | 386.11% | 95.43% | 108.90% | -352.00% |